RVL Pharmaceuticals PLC (FRA:O1P)
€ 0.003 0 (0%) Market Cap: 1.65 Mil Enterprise Value: 38.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Osmotica Pharmaceuticals PLC at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 03:15PM GMT
Release Date Price: €4.66 (-1.27%)
Operator

You may begin.

Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO

Thank you, operator, and good morning. This is Brian Markison, CEO of Osmotica Pharmaceuticals. With me today is also Andrew Einhorn, our Chief Financial Officer, and we'd like to welcome you to our Investor Presentation, virtually.

So the presentation that I will be reviewing with you will be available and is available on our website, and we'll be -- I'll be referencing the page numbers that are on the presentation as we go through it.

So on the second page of our presentation, and please note the safe harbor. I won't read it, but it's there on Page #2.

Page #3 basically describes Osmotica is a fully integrated and diversified pharmaceutical company. We have development and commercialization expertise, and we participate in a number of target markets.

Slide #4, Osmotica Corporate Strategy. We're embarking on a journey where we are leveraging our core capability. We have a number of near-term exciting pipeline opportunities, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot